Mark Coleman - 15 Mar 2022 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role: Director
Signature: /s/ Mark Coleman
Issuer symbol: AXSM
Transactions as of: 15 Mar 2022
Net transactions value: +$4,545
Form type: 4
Filing time: 17 Mar 2022, 07:05:10 UTC
Previous filing: 08 Mar 2022
Next filing: 07 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXSM	Common Stock	Options Exercise	$4,545	+3,496	+85%	$1.30^*	7,596	15 Mar 2022	Direct	F1
holding	AXSM	Common Stock						422,428	15 Mar 2022	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXSM	Stock Option (Right to Buy)	Options Exercise	$0	-3,496	-17%	$0.000000	17,501	15 Mar 2022	Common Stock	3,496	$1.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an exercise of stock options and hold of underlying shares.
F2	Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.